Background
Blast injuries are deemed the signature wounds of the first wars (Afghanistan and Iraq) of the 21st century (Lancet, 2007; Galarneau et al., 2008) . According to a recent U.S. Department Veterans Affairs (DVA) and Defense (DoD) report, 12-23% of returning service members reported a TBI during deployment (O'Neil et al., 2013) . Of these, the majority are in the ''mild'' range of severity (mTBI) (Centers for Disease Control and Prevention and National Center for Injury Prevention and Control 2003; Hoge et al., 2009; O'Neil et al., 2013) . A review of the literature from 20th century wars (WWI, WWII, Vietnam) shows that current lines of scientific inquiry regarding the etiology of those symptoms parallel earlier attempts to disentangle the pathophysiology of post-concussive symptoms (PCS) from mental health symptoms, and to distinguish mTBI from war-related mental health syndromes, such as PTSD (Jones et al., 2007) . Moreover this literature highlights limitations in methodology and attribution of symptom etiology, be it organic, psychological, or behavioral, that remain a focus of investigations today (Myers, 1915; Fulton, 1942; Jones et al., 2007; Rosenfeld et al., 2013) .
A particular challenge in disentangling the symptoms and physiology has been establishing a quantitative, unassailable diagnostic methodology for defining mTBI, such a distinguishing blood or imaging biomarker signature. Most studies have relied on self-report of a concussive event, and have defined mTBI clinically, using symptom-based criteria. Brain changes that may accompany mTBI have been hard to visualize using standard imaging methods (Huang et al., 2012) . While neurocognitive tests are used clinically and can be helpful, authors of the recent U.S. DVA Report observed that only a few studies among those reviewed found an association between mTBI and cognitive deficits (O'Neil et al., 2013) . However, longitudinal follow-up of military personnel initially evacuated to Longstuhl with mTBI (self-report of war-related brain injury event) showed that rates of disability 6-12 months after evacuation were high and outcomes worse, overall in those service members with mTBI, comparable to those of civilian cohorts or polytrauma patients with mTBI (MacDonald et al., 2014) . MacDonald et al. found no substantial differences in cognition between the evacuated personnel with and without a history of mTBI, however rates of PTSD and depression were higher in the mTBI group (MacDonald et al., 2014) .
A substantial number of cross-sectional studies have shown higher (nearly double) rates of PTSD in individuals with mTBI, observed in both military (Hoge et al., 2008; Schneiderman et al., 2008; Luethcke et al., 2011; Vasterling et al., 2012; Rosenfeld et al., 2013) and civilian (Bryant et al., 2010; Mayou et al., 2000) settings. Moreover, these findings have been corroborated using prospective study designs in civilians (Roitman et al., 2013) and in active duty service members (Yurgil et al., 2014) . In an 10 day and 8 month follow-up of civilians who presented to the emergency room as a result of motor vehicle accidents, some with mTBI (<30 min loss of consciousness) and some without, Roitman et al., showed that those with head injury and loss of consciousness (LOC) had higher levels of PTSD at follow-up. In the Marine Resiliency Study (MRS), a prospective, longitudinal study, of Marines and Sailors assessed at pre-deployment and again at 3-6 months after a 7-month deployment to Iraq or Afghanistan rates of reported prior TBI were 56.8% at the pre-deployment interview, and rates of deployment-related TBI were 19.8%; of the deployment-related TBIs approximately 87.2% were mild Yurgil et al., 2014) . As was observed in the civilian study, war-related mTBI significantly increased post-deployment PTSD symptom scores, either doubling or nearly doubling the PTSD rates in combatants who, prior to deployment, had been mentally healthy (Yurgil et al., 2014) .
These two prospective studies provide accumulating evidence that mTBI is a robust prognostic indicator of subsequent PTSD development, raising the question as to the underlying cause. Whereas heightened emotional salience of traumatic events that involve blast/concussive injuries versus those without may, in part, provide an explanation for higher PTSD rates after mTBI, another likely, or perhaps even primary explanation may be that mTBI associated structural and functional brain changes increase vulnerability for development of mental disorders such as PTSD (Yurgil et al., 2014) . Damage of the mTBI prefrontal cortical networks implicated in PTSD has been suggested as a possible cause of the increased vulnerability (Hoffman and Harrison, 2009; Yurgil et al., 2014) .
Pre-clinical studies, as described below, focused on the pathophysiology and mechanisms of neurotrauma may contribute important information regarding mTBI associated brain changes that may contribute to PTSD development. These studies are needed to form a solid scientific basis
Preclinical
The use of improvised explosive devices (IEDs) in contemporary asymmetric warfare has changed the scene and spectrum of TBI at the battlefield. The signature TBI has changed from penetrating during the war in Vietnam to blast induced TBI. At the same time, new equipment for body protection has increased the survival rate after TBI at the battlefield. A blast injury is a complex type of physical trauma and includes a variety of injuries, ranging from mild to lethal. The majority of blast induced TBI fall into the category of mild TBI (Hoge et al., 2008) and several groups have tried to develop relevant experimental models for mild blast TBI. It is not possible to make a full review of all experimental research with a focus on blast induced TBI here. However, it is important to underscore the different physics in blast TBI and TBI in a civilian setting, more frequently a result of blunt trauma injury. Extreme forces and their complex propagation characterize blast TBI.
Injury from blast can result from secondary, tertiary and even quaternary effects as well as the primary supersonic pressure wave produced by the blast, all of which have been studied in brain injury models. Secondary effects, due to the impact of flying objects, such as shrapnel fragments, can generate penetrating injuries. The proportion of such injuries was larger in previous conflicts, but seems to have been reduced by improvements in helmet construction. Tertiary effects of blast result from acceleration/deceleration trauma, which may result in tissue shearing and diffuse injuries, such as DAI (diffuse axonal injuries). If the trauma is rotational, the position of the axis of rotation will be an important factor in the injury mechanism and areas at a greater distance from this axis will sustain larger forces. Quaternary effects of blast result from heat, smoke or emission of electromagnetic pulses from detonations (Lee et al., 2011) .
If the injury is associated with fragment penetration this will induce more severe focal injury, with subsequent diffuse secondary injuries due to propagation of pressure waves and temporary cavities. Secondary traumatic brain damage occurs as a complication of the different types of TBI and includes ischemic and hypoxic damage, swelling, raised intracranial pressure and infection. The secondary TBI is potentially partly reversible with adequate treatment. Many clinical TBI patients suffer from multiple injuries, i.e. pulmonary lesions or amputations, which can have effects on the outcome of the TBI (due to hypoxia or systemic inflammation). The complexity of the clinical injury and the fact that exposure data seldom are available has created a need for experimental research on biological effects of blast. One early example of this research is the PhD thesis by Carl-Johan Clemedson ''An experimental study on air blast injuries'' (Clemedson, 1949) . During the 65 years that have passed since that publication, a considerable number of animal models have been proposed suitable for research on blast induced TBI. The primary blast wave is the propagation of a supersonic pressure wave with short duration. The threshold for injuries is determined by factors such as peak pressure, duration and shape of the wave (reflections, underpressure etc.). Models for better understanding the primary blast wave include (1) open field exposure, (2) blast tubes for explosives and (3) Shock tubes with compressed air or gas.
• Open field exposure. Examples here are the large-scale classical experiments in the U.S. in desert areas and ponds, employing large sets of animals of different species and sizes. These experiments determined thresholds for bleeding in air filled organs such as the lungs and intestines, but the potential effects on the central nervous system were not assessed. For simple waveforms, i.e. the Friedländer type of wave, dose response curves (the Bowen curves) were determined.
• Blast tubes for explosives. During 1950s large size blast tubes were created to study effects of wave forms relevant to nuclear detonations, i.e. comparatively long duration of the primary peak. The tubes were often used to study how construction details such as doors could withstand a blast wave. One exception was the studies by Clemedson at the Swedish FOA (Swedish Defence Research Establishment) using a smaller blast tube (Clemedson and Criborn, 1955) in which a charge of plastic explosive was used. These types of systems are still in use, but have been outnumbered by shock tube systems.
• Shock tubes with compressed air or gas. Systems with compressed air were used already in the 1950s (Celander et al., 1955) . Most systems comprise two chambers, separated by a membrane. The gas is loaded into an overpressure chamber (the driver section), which is separated from the main compartment (driven section) by a membrane (diaphragm). The object, i.e. the experimental animal is positioned somewhere in the main section. The operator of the system can rupture the diaphragm at a predetermined pressure and the compressed gas enters the main section as a blast wave. The main section is usually several meters long. If more than one overpressure chamber is positioned in a series rather complex waveforms can be created (Cernak et al., 2011) . One advantage with this type of shock tube is the absence of quaternary blast effects and other disadvantages of explosives. However, this advantage can also be regarded as a disadvantage.
One significant problem with the variety of experimental models for blast TBI is that it is very difficult to actually compare the different models. For example, there is no real consensus for monitoring of pressure curves for different models for primary blast. Researchers seem to disagree about recording techniques to access peak pressure, duration and acceleration movements. Blast waves cause damage by a combination of the compression of the air in front of the wave and the subsequent wind, but there is no real consensus on how to represent such parameters in the laboratory situation. Experimental models should be carefully validated in terms of physical parameters (AntonaMakoshi et al., 2014) and outcome (morphologic, functional, molecular and gene expression changes) . All methods that could facilitate a good translation to clinical data (serological biomarkers, neurophysiolgy and imaging) are recommended. Dr. Ibolja Cernak has shown that blast TBI can be a systemic reaction to blast (Cernak, 2010) . General inflammatory reactions from the primary blast can contribute to the reactions of the brain. The propagation of pressure waves through the body in blast trauma is still a subject of disagreement. Important data can be retrieved by carefully planned experiments utilizing incomplete body protection (Cernak, 2010) . The importance of repeated mild TBI for development of late development of neurodegenerative disease has been documented in sports medicine (Guskiewicz et al., 2005) and repeated injuries will undoubtedly be included in a number of protocols for research on blast TBI. Studies on operators in breaching training can provide a very interesting strategy to collect good exposure data and biomarkers after repeated controlled detonations (Tate et al., 2013) . One central problem is that exposure data from actual clinical situations are lacking. Acceleration probes mounted in helmets may help to solve this problem and if the same type of sensors will be implanted for use in animal experiments translation of data may be facilitated.
As noted above, veterans with histories of blast-induced mTBI who have been exposed to explosions are more likely to have headaches, features of migraine, more severe pain, PTSD, and impaired sleep with nightmares. It is difficult to achieve a good representation of such parameters in the evaluation of animal experiments for blast TBI, i.e. blast models that make use of rodents and pigs. Refined behavioral tests with a high sensitivity for stress reactions similar to posttraumatic stress will be important in the future work with blast Kovesdi et al., 2011; Kwon et al., 2011) . Additional experiments are required to enable an understanding of the co-morbidity of TBI and PTSD. Such experiments could be combined with biomarker sampling, behavior analysis such as the Forced Swim Test and functional imaging. A recent study has revealed significant changes in catecholamines and serotonin in rodents exposed to a mild TBI (Kawa et al., 2014) .
One way to accomplish a better translation between animal experiments and the clinic would be to employ the same methodology for analysis. Imaging, e.g. with MRI (Kamnaksh et al., 2014) or magnetoencephalogram (MEG), and systematic use of biomarkers can be used in both settings and help to bridge the gap between the lab bench and the hospital bed (Agoston et al., 2012) . It is important to consider that the limited size of rodent brains creates a demand for good resolution in the imaging technique. Strain differences between different rodents may create difficulties in the interpretation of biomarkers. Different timetables for injury induced changes in biomarkers between rodents and humans should also be considered. Computer based reconstruction of clinical injuries and exposure in the experimental models can help to narrow the knowledge gap between experiments and clinical observations (Kleiven, 2007) . Fine-tuning of the finite element models would need to include both tissue properties and a proper representation of fiber tracts. Modeling however, has limited use if the predictions cannot be validated by actual biological observations. The different geometrical shape of the rodent brain and humans can create obstacles in modeling. It is therefore advantageous if data from larger animals, such as pigs, are available also.
The Vietnam Head Injury study can also be used as an example of translation. Outcome data from a large cohort of patients that survived penetrating brain injuries has been analyzed during more than 35 years . This is probably one of the most detailed follow-up neurotrauma studies that has ever been conducted. This material has been employed to reveal the importance of the growth factor BDNF on the outcome of the injury an observation that later was brought back for further investigation in a suitable animal model (Rostami et al., 2014) .
In summary, blast TBI involves complex energy transfer and several possible mechanisms. The primary blast wave, acceleration generated tissue strain, smoke and heat can induce both mild TBI and more severe injuries. It is essential to have a good control on physics during animal experiments on blast induced TBI. Translation to clinical situations can be facilitated if serological biomarkers and advanced imaging techniques can be used.
Clinical
In humans, the observation that repeated mild injuries could result in chronic traumatic encephalopathy (CTE) (Lakis et al., 2013; Stein et al., 2014) . has influenced scientists to start experimental projects on repeated mild blast induced TBI (Petraglia et al., 2014a,b; Glushakova et al., 2014; Goldstein et al., 2014) .
Also there is now evidence that changes in endocrine functions and regulation can show significant changes in TBI patients. Serum levels of melatonin can probably contribute to long-term sleep disturbances in TBI patients (Seifman et al., 2014) . It has been observed that pituitary dysfunction may be one of the consequences of blast TBI (Baxter et al., 2013) and this observation should be analyzed also in experimental models for blast.
Of course, there is an extensive pre-clinical and clinical literature showing abnormalities in neuroendocrine function in PTSD, review of which is beyond the focus of this paper (de Kloet et al., 2006; Krystal and Neumeister, 2009 ). Plasma melatonin levels collected 48 h after a trauma in Australian troops are reported to predict later PTSD, but, a recent study that assessed polysomnography with simultaneous blood sampling in returning Dutch troops observed no PTSD-related plasma melatonin abnormalities, despite sleep disturbance van Liempt et al., 2013) . The same Dutch study, though, showed evidence for a link between hypothalamic-pituitary-adrenal (HPA) axis abnormalities that were observed and sleep disturbance in the troops with PTSD (van Liempt et al., 2013) .
To date most neuroendocrine research has focused on either PTSD or mTBI and has not grappled with the complexities of disentangling effects of possible co-occurring disorders. Clearly, going forward, as our ability to detect post-head injury residual brain injury improves, it will be important to carefully characterize diagnostic status (mTBI, PTSD and the combination) in endocrine and autonomic research in military cohorts in order to fully tease apart biomarkers related to separate (mTBI, PTSD) and combined (mTBI and PTSD) status, given the high co-occurrence of both disorders in deployed troops.
Inflammatory reactions and cell death after TBI can be different in males and females (Gunther et al., 2015) . Role of biomarkers in PTSD and mTBI 5
Such differences can possibly be related to endocrine functions. Also metabolic functions can be altered after TBI. For example, changes in the cytochrome p450 superfamily of metabolic enzymes could influence the metabolism of inflammatory mediators, drugs and hormones (Birnie et al., 2013) . Metabolic abnormalities have been proposed, but are yet to be studied in humans with PTSD (Naviaux, 2014) . At present, it is unclear why similar mTBI events can lead to dramatic neurobehavioral decompensation with persistent PCS in some individuals, but not in others (Jeter et al., 2013) . Retrospective and prospective studies of combatrelated TBI show that most (<85%) deployment-related TBIs are mild (MacGregor et al., 2011; Yurgil et al., 2014) . But diagnoses are based primarily on the characteristics of the acute clinical sequelae following the injury. The subtle, scattered and varied lesion(s) usually go undetected by conventional CT, and they are often unobservable on conventional MRI as well (Van Boven et al., 2009; Bigler and Orrison, 2004; Johnston et al., 2001; Kirkwood et al., 2006) . Teasdale and Jennet showed that intracranial lesions in mTBI are detected by conventional neuroimaging techniques in only 4%, 16%, and 28% of patients with Glasgow Coma Scale scores (GCS) (Teasdale and Jennett, 1974) of 15, 14, and 13, respectively (Culotta et al., 1996) .
Usually, the persistent PCS and cognitive deficits in TBI patients cannot be explained solely by focal pathology. DAI is a major contributor to these deficits and is commonly induced by sudden acceleration-deceleration or rotational forces. In a rodent TBI model, axonal injury was the most prominent feature following blast exposure (Garman et al., 2011) . In humans, the subsequent tissue injury is characterized by axonal stretching, inflammation, disruption, and separation of nerve fibers, although axotomy is relatively rare in even severe TBI (Adams et al., 1989; Basser and Pierpaoli, 1996; Gennarelli et al., 1982; Xu et al., 2007) . Conventional CT and MRI are primarily sensitive to blood from nearby torn capillaries, rather than axonal damage itself, hence they underestimate the presence of DAI, especially in mTBI. New approaches using diffusion tensor imaging (DTI), positron emission topography (PET), and macromelecular proton fraction (MPF) have showed promising capability in detecting injuries and/or abnormalities that are not visible in CT and MRI (e.g., Petrie et al., 2014; MacDonald et al., 2011; Davenport et al., 2012; Shenton et al., 2012) .
Magnetoencephalogram (MEG) is a non-invasive functional imaging technique that directly measures the magnetic signal due to neuronal activation in gray matter (GM) with high temporal resolution (<1 ms) and spatial localization accuracy (2-3 mm at cortical level) (Leahy et al., 1998) . MEG demonstrates sensitivity to abnormal neuronal signals resulting from axonal injuries. Neurophysiological studies in animals have established a solid connection between pathological delta-wave (1-4 Hz) generation in GM and axonal injuries in WM. Gloor et al. showed that polymorphic delta-band slow-waves produced by (white matter) WM axonal lesions in the cat were localized to the GM area of cortex overlying the lesion Gloor et al., 1977) . They also found that pathological delta-waves can be induced by the administration of atropine in the WM (Schaul et al., 1978) . It is known that atropine is a competitive antagonist of acetylcholine receptors and can block and/or limit the cholinergic pathway. These experiments concluded that cortical de-afferentation was an important factor in abnormal delta-wave production, owing to WM lesions (i.e., axonal injury) and/or defects in the cholinergic pathway (Schaul, 1998) . In the human brain, the projections of cholinergic pathways highly overlap with the WM fiber tracts (Selden et al., 1998) , which make the cholinergic pathways similarly susceptible as the WM tracts to TBI.
Human studies by Lewine et al., and our laboratory showed that the brains of mTBI patients generate abnormal low-frequency magnetic fields that can be measured and localized by resting-state MEG (Huang et al., 2009 (Huang et al., , 2012 Lewine et al., 1999 Lewine et al., , 2007 . MEG was also found to be more sensitive than conventional MRI or EEG in detecting abnormalities in mTBI patients (Lewine et al., 1999 (Lewine et al., , 2007 . Unlike normal resting-state MEG data, which is dominated by neuronal activity with frequencies above 8 Hz, injured neuronal tissues (due to head trauma, brain tumors, stroke, and epilepsy) generate abnormal focal or multi-focal lowfrequency neuronal magnetic signals (delta-band 1-4 Hz, or theta-band 5-7 Hz) that can be directly measured and localized using MEG de Jongh et al., 2003; Decker and Knott, 1972; Lewine et al., 1999; Lewine and Orrison, 1995; Nagata et al., 1985; Vieth et al., 1996) . While TBI is not the only neurological disorder that generates abnormal slow-wave, in practice, brain tumors, stroke, and epilepsy can be easily ruled out based on structural imaging (i.e., CT and MRI for tumor and stroke) and medical history (for epilepsy). Fig. 1 shows an example of the abnormal resting-state MEG slow-wave findings in one of studies (Huang et al., 2009 ) from a chronic mTBI patient (sport injury) with persistent PCS including: pressure headaches, dizziness, fatigue, memory problems, difficulty falling asleep, and changes in speech and language. Multiple clinical CT and MRI scans were all negative. Fig. 1 shows that the abnormal MEG slow-waves came from: (1) lateral superior-posterior left temporal lobe, and (2) an area containing three sub-regions in the ventral right temporal and occipital lobes (Huang et al., 2009) . Deafferentation due to axonal injuries was most likely the cause of slow-waves in these GM regions which was confirmed by Diffusion Tensor Imaging (DTI) tractography analysis (Huang et al., 2009) .
In a separate region-of-interest (ROI) study from our lab (Huang et al., 2012) , we assessed abnormal resting-state MEG slow-wave (1-4 Hz) generation from 96 cortical regions from three TBI groups: 23 mild TBI patients exposed to combat-related blasts, 22 mild TBI patients with non-blast causes (sports, motor vehicle accidents, fall, and assault), and 10 moderate TBI patients with non-blast causes. The normative database for the ROI-based MEG slow-wave power was established using data from 44 healthy control subjects. Fig. 2 shows a conservative threshold (horizontal line) in which all healthy control subjects' slow-wave measures were below this level (0% false-positive rate). With such a threshold, the positive detection rates were 96% for mild blast-induced TBI patients (22 out of 23), 77% for the mild non-blast TBI patients (17 out of 22), and 100% for the moderate TBI patients (10 out of 10). When we combined the blast-induced and non-blast mild TBI groups together, the correct diagnostic rate was about 87% for the combined mild TBI group. This study provides a foundation for using Role of biomarkers in PTSD and mTBI 7
Figure 3 MEG source imaging in beta and gamma bands shows hyperactivities (PTSD > Ctrl, red-hot color) from amygdala/anterior hippocampus and hypoactivities (PTSD < Ctrl, blue-cold color) from the vmPFC, with corrected p < 0.05 in beta-gamma band.
MEG low-frequency source imaging as potential biomarker to assist in the clinical diagnosis of mild TBI. Recently, we expanded the above ROI-based approach by developing a voxel-based whole-brain MEG slow-wave imaging approach, Fast-VESTAL , for detecting abnormality in patients with mTBI on a singlesubject basis . A normative database of resting-state MEG source magnitude images (1-4 Hz) from 79 healthy control subjects (68 civilians and 11 active-duty military service members) was established for all brain voxels. The high-resolution MEG source magnitude images were obtained by our recent Fast-VESTAL method. In 84 mTBI patients with persistent post-concussive symptoms (36 from blasts, and 48 from non-blast causes), our method detected abnormalities at the positive detection rates of 84.5%, 86.1%, and 83.3% for the combined (blast-induced plus with non-blast causes), blast, and non-blast mTBI groups, respectively. We found that prefrontal, posterior parietal, inferior temporal, hippocampus, and cerebella areas were particularly vulnerable to head trauma. The results also showed that MEG slow-wave generation in prefrontal areas positively correlated with personality change, trouble concentrating, affective lability, and depression symptoms.
Amygdala, vmPFC, and hippocampal regions implicated in pre-clinical fear processing are thought to be dysfunctional in PTSD (Rauch et al., 1998 (Rauch et al., , 2006 . Functional neuroimaging findings using positron emission topography (PET) and functional magnetic resonance imaging (fMRI) suggest that individuals with PTSD exhibit hyperresponsive amygdala activity to trauma or fear-related stimuli (for review, see Shin and Liberzon, 2010) , during emotionally neutral tasks (Bryant et al., 2005; Shin et al., 2004b) , and even at rest (Chung et al., 2006; Semple et al., 2000) . A hyperresponsive amygdala contributes to the exaggerated fear response characteristic of PTSD (Anderson et al., 2003) . Conversely, PTSD has been associated repeatedly with hyporesponsive vmPFC (for review, see Hughes and Shin, 2011) . Hyporesponsive PFC, as well as reduced connectivity to the amygdala (Jin et al., 2013; Shin et al., 2004a) may indicate insufficient inhibitory control over exaggerated fear responses. Lastly, abnormal hippocampal function (Corcoran and Maren, 2001) and reduced connectivity to the amygdala (Dolcos et al., 2004; McGaugh, 2004 ) may underlie impairments in contextual memory processing and the ability to inhibit intrusive memories (Shin et al., 2004a) , although findings have been mixed (Hughes and Shin, 2011) . A recent resting-state fMRI study showed increased activity in amygdala and reduced spontaneous neural activity in the dorso-lateral PFC (DLPFC) (Yan et al., 2013) . However, the authors found no evidence of abnormal resting-state fMRI signal in the vmPFC.
Recently, we used resting-state MEG to study 16 OEF/OIF active-duty military and veteran participants with PTSD, and 23 age-matched healthy control subjects. Among the control subjects, 12 were active-duty military personnel deployed to Iraq and/or Afghanistan and 11 were civilians without military training. Voxel-based whole brain MEG source magnitude images were obtained using our new Fast-VESTAL high-resolution MEG source imaging method . Fig. 3 shows that for beta-gamma band (15-80 Hz), increased MEG activity in PTSD (hyperactivities, PTSD > controls) was generated from bilateral amygdala/anterior hippocampus, whereas decreased MEG activity was generated from the vmPFC. The MEG results were consistent with the theory that reduced inhibition (hypoactivity) from the vmPFC and hyperactivity in the ''fear network'' including the amygdala/anterior hippocampus are closely related. These data suggest that MEG imaging may accurately visualize brain evidence of PTSD, but more research is needed to fully develop MEG as a potential biomarker for PTSD.
As discussed earlier, TBI significantly potentiates PTSD development. Here we present some preliminary data of using a voxel-based MEG source imaging approach to evaluate the potentiation of PTSD by an mTBI. The new aspect of the study is to provide much needed information regarding exactly what brain regions that are part of the abnormal PTSD neurocircuitry are also particularly vulnerable to mTBI. Such information may contribute to more effective treatments for veterans with comorbid mTBI and PTSD, and guide the development of preventive strategies in PTSD.
Please cite this article in press as: Huang 4 shows preliminary data of abnormal MEG slowwaves from 4 patients with comorbid mTBI and PTSD. All patients showed abnormal slow-waves (1-4 Hz) from vmPFC, 3 out of 4 showed bilateral dlPFC abnormal slowwaves, and 1 showed right dlPFC abnormal slow-wave generation, indicating potential injuries due to mTBI. The slow-wave generation suggests mTBI in these PFC areas. In addition, similar to the preliminary result from the group of 25 PTSD subjects, these 4 comorbid patients also showed MEG hypoactivity from vmPFC and dlPFC in high frequency bands when compared with the HCs, similar to the findings presented in Fig. 3 . In this comorbid group, the co-existence of abnormal MEG slow-wave (mTBI component) and hypoactivity from vmPFC and dlPFC in high frequency bands (PTSD component) suggests the mTBI injuries in PFC may result in a lack of inhibition from PFC to other areas of the PTSD neurocircuitry. This preliminary data, thus, provides evidence of abnormal slow-wave generation in these PFC areas due to mTBI and the potentiation of PTSD.
Limitations of this study
There are several limitations of this study: One concern with neuroimaging studies, including many recent studies involving OIF/OEF veterans, are the reliance on convenience samples and the use of control groups that do not always provide adequate scientific comparisons Castro, 2011, 2014) . Next, we have focused on the potentiation of PTSD development due to mTBI. Deployment to Iraq or Afghanistan, as in past wars, is certainly associated with non-specific generalized physical and cognitive health effects, and it is likely that there are multiple causes for these health concerns beyond mTBI and PTSD (e.g. prolonged periods of sleep deprivation, combat intensity, intense physical strain on the body from harsh foot patrols, depression, repetitive load-bearing injuries, etc.) (Hoge and Castro et al., 2014) . Also, deployment experiences are highly variable. Roughly two-thirds of OIF/OEF service members worked principally inside heavily fortified compounds with limited exposure to war-zone stressors (other than random indirect fire). The other one-third, mostly infantry brigades, have done the lion's share of the direct combat heavy lifting, but even in those units there is high variability of exposure experiences. Clearly service members in units that experience more direct combat, higher levels of sleep deprivation, and more non-head injuries will likely have higher rates of non-specific abnormalities on functional neuroimaging (to include vmPFC or dlPFC) than comparison groups that did not have this level of deployment intensity, and thus it is important in future studies to consider these factors when designing studies that attempt to look at the neuroimaging associated with blast, mTBI or PTSD cases. In the present study, our control group for the MEG slowwave source imaging study contains a mix of active-duty military and civilian subjects. This mix was necessary since we assessed both subjects with blast-induced mTBI as well as civilian mTBI subjects without blast exposure. Nevertheless, the imbalance of active-duty military subjects between the control and blast mTBI groups remains a limitation.
Also, as noted previously, the focus of this paper is on mTBI and on MEG imaging, thus an exploration of the full range of biomarkers, in particular the large literature on blood-based biomarkers in PTSD, was beyond the scope of this paper. The common co-existence of mTBI and PTSD pose further significant challenges for blood-based biomarker research in both mTBI and PTSD in military and veteran populations, since co-occurrence of either must be assessed, Role of biomarkers in PTSD and mTBI 9
and considered during study enrollment, and is a limitation of current research. Since blast exposure is a risk for PTSD development, and there is significant overlap in PTSD and mTBI, an ultimate goal of the MEG research will be the development imaging biomarkers for PTSD, and for mTBI on a single subject basis, i.e. diagnostic biomarkers.
Conclusion
In summary, TBI is a highly prevalent condition, although the majority of cases of TBI are mild. While the social and fiscal impact of moderate and severe TBI has been well known, until recently, the potential negative impact of mTBI on health has been underappreciated. In contrast to tools available in the 20th century, we now have great advancements in technology that, combined with pre-clinical insights, can support development of improved approaches for clinical visualization of the mTBI injuries, which may provide a basis for a new schema for mTBI diagnosis. With more precise diagnostic approaches, such as high resolution imaging, and cerebrospinal fluid or blood testing, we may ultimately be able to develop imaging and bodily fluid biomarkers for use in prognosis, diagnosis, or as treatment outcome measures.
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